| Protein misfolding and neurodegeneration C Soto, LD Estrada Archives of neurology 65 (2), 184-189, 2008 | 424 | 2008 |
| Amyloids, prions and the inherent infectious nature of misfolded protein aggregates C Soto, L Estrada, J Castilla Trends in biochemical sciences 31 (3), 150-155, 2006 | 336 | 2006 |
| De novo induction of amyloid-β deposition in vivo R Morales, C Duran-Aniotz, J Castilla, LD Estrada, C Soto Molecular psychiatry 17 (12), 1347-1353, 2012 | 239 | 2012 |
| Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases R Morales, LD Estrada, R Diaz-Espinoza, D Morales-Scheihing, MC Jara, ... Journal of Neuroscience 30 (13), 4528-4535, 2010 | 229 | 2010 |
| Disrupting β-amyloid aggregation for Alzheimer disease treatment LD Estrada, C Soto Current topics in medicinal chemistry 7 (1), 115-126, 2007 | 200 | 2007 |
| Role of oxidative stress as key regulator of muscle wasting during cachexia J Ábrigo, AA Elorza, CA Riedel, C Vilos, F Simon, D Cabrera, L Estrada, ... Oxidative medicine and cellular longevity 2018, 2018 | 182 | 2018 |
| Amyloid formation modulates the biological activity of a bacterial protein S Bieler, L Estrada, R Lagos, M Baeza, J Castilla, C Soto Journal of Biological Chemistry 280 (29), 26880-26885, 2005 | 145 | 2005 |
| Smoking exacerbates amyloid pathology in a mouse model of Alzheimer’s disease I Moreno-Gonzalez, LD Estrada, E Sanchez-Mejias, C Soto Nature communications 4 (1), 1495, 2013 | 124 | 2013 |
| Liver dysfunction as a novel player in Alzheimer’s progression: looking outside the brain LD Estrada, P Ahumada, D Cabrera, JP Arab Frontiers in aging neuroscience 11, 174, 2019 | 107 | 2019 |
| EphA4 activation of c-Abl mediates synaptic loss and LTP blockade caused by amyloid-β oligomers L M. Vargas, N Leal, LD Estrada, A Gonzalez, F Serrano, K Araya, ... PloS one 9 (3), e92309, 2014 | 103 | 2014 |
| c-Abl stabilizes HDAC2 levels by tyrosine phosphorylation repressing neuronal gene expression in Alzheimer’s disease M Gonzalez-Zuniga, PS Contreras, LD Estrada, D Chamorro, A Villagra, ... Molecular cell 56 (1), 163-173, 2014 | 88 | 2014 |
| Amyloid inhibitors and β-sheet breakers C Soto, L Estrada Alzheimer’s Disease: Cellular and Molecular Aspects of Amyloid β, 351-364, 2005 | 66 | 2005 |
| Inhibition of protein misfolding and aggregation by small rationally-designed peptides LD Estrada, C Soto Current pharmaceutical design 12 (20), 2557-2567, 2006 | 54 | 2006 |
| Trends and innovations of simulation for twenty first century medical education E Herrera-Aliaga, LD Estrada Frontiers in public health 10, 619769, 2022 | 53 | 2022 |
| Diet-induced nonalcoholic fatty liver disease is associated with sarcopenia and decreased serum insulin-like growth factor-1 D Cabrera, A Ruiz, C Cabello-Verrugio, E Brandan, L Estrada, M Pizarro, ... Digestive diseases and sciences 61, 3190-3198, 2016 | 53 | 2016 |
| Transforming growth factor beta type I role in neurodegeneration: implications for Alzheimer s disease LD Estrada, L Oliveira-Cruz, D Cabrera Current Protein and Peptide Science 19 (12), 1180-1188, 2018 | 48 | 2018 |
| Functionalization of stable fluorescent nanodiamonds towards reliable detection of biomarkers for Alzheimer’s disease F Morales-Zavala, N Casanova-Morales, RB Gonzalez, A Chandía-Cristi, ... Journal of nanobiotechnology 16, 1-14, 2018 | 40 | 2018 |
| TGF-β and hepatocellular carcinoma: when a friend becomes an enemy M Arrese, A Hernandez, L Astete, L Estrada, C Cabello-Verrugio, ... Current Protein and Peptide Science 19 (12), 1172-1179, 2018 | 33 | 2018 |
| Reduction of blood amyloid-β oligomers in Alzheimer’s disease transgenic mice by c-Abl kinase inhibition LD Estrada, D Chamorro, MJ Yáñez, M Gonzalez, N Leal, ... Journal of Alzheimer's Disease 54 (3), 1193-1205, 2016 | 29 | 2016 |
| Abl Tyrosine Kinase Signaling: A New Player in AD Tau Pathology LD Estrada, SM Zanlungo, AR Alvarez Current Alzheimer Research 8 (6), 643-51, 2011 | 26 | 2011 |
DANIEL CABRERAUniversidad de los AndesDirección de correo verificada de uandes.cl
